The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats

European Journal of Pharmacology

Volumn 528, Issue 1-3, 2005, Pages 88-94

  Wirtshafter, David ^a   Osborn, Catherine V ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

c fos; cAMP; Caudate; Dopamine D2 receptor; Rotation; SKF83959; Striosome

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 3 METHYL 1 (3 METHYLPHENYL) 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENYLATE CYCLASE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; OXIDOPAMINE; PHOSPHOLIPASE C; PROTEIN C FOS; QUINPIROLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DENERVATION; DOPAMINE METABOLISM; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC SYSTEM; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SELECTIVITY; DRUG TARGETING; MALE; NEUROPHARMACOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ROTATION; SIGNAL TRANSDUCTION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; BRAIN; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MODELS, ANIMAL; MOTOR ACTIVITY; OXIDOPAMINE; PROTO-ONCOGENE PROTEINS C-FOS; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SIGNAL TRANSDUCTION; SYMPATHECTOMY, CHEMICAL;

EID: 28844483449     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2005.11.003     Document Type: Article

References (52)

1. M. Andersson, C. Konradi, and M.A. Cenci cAMP response element binding protein is required for dopamine-dependent gene expression in the intact but not the dopamine-deinnervated striatum J. Neurosci. 21 2001 9930 9943
2. G. Andringa, B. Drukarch, J.E. Leysen, A.R. Cools, and J.C. Stoof The alleged dopamine D1 receptor agonist SKF 83959 is a dopamine D1 receptor antagonist in primate cells and interacts with other receptors Eur. J. Pharmacol. 364 1999 33 41
3. J. Arnt, J. Hyttel, and C. Sanchez Partial and full dopamine D1 receptor agonists in mice and rats: relation between behavioral effects and stimulation of adenylate cyclase activity Eur. J. Pharmacol. 213 1992 259 267
4. K.E. Asin, and D. Wirtshafter Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression Eur. J. Pharmacol. 235 1993 167 168
5. K.E. Asin, L. Bednarz, A. Nikkel, and R. Perner Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa J. Pharmacol. Exp. Ther. 273 1995 1483 1490
6. C. Bergson, R. Levenson, P.S. Goldman-Rakic, and M.S. Lidow Dopamine receptor-interacting proteins: the Ca2+ connection in dopamine signaling T.I.P.S. 24 2005 486 492
7. A. Berod, B.K. Hartman, and J.F. Pujol Importance of fixation in immunocytochemistry: use of formaldehyde solutions at variable pH for the localization of tyrosine hydroxylase J. Histochem. Cytochem. 29 2004 844 850
8. C. Capper-Loup, J.J. Canales, N. Kadaba, and A.M. Graybiel Concurrent activation of dopamine D1 and D2 receptors is required to evoke neural and behavioral phenotypes of cocaine sensitization J. Neurosci. 22 2002 6218 6227
9. J.J. Clifford, O. Tithe, D.T. Croke, A. Kinsella, D.R. Sibley, J. Drago, and J.L. Waddington Conservation of behavioural topography to dopamine D1-like receptor agonists in mutant mice lacking the D1A receptor implicates a D1-like receptor not coupled to adenylyl cyclase Neuroscience 93 1999 1483 1489
10. D.F. Cook, and D. Wirtshafter Quinpirole attenuates the striatal immediate early gene expression, but not the hyperactivity, induced by the serotonin agonist RU-24969 Brain Res. 852 2000 247 254
11. A.R. Cools, L. Lubbers, R.V. van Oosten, and G. Andringa SKF 83959 is an antagonist of dopamine D1-like receptors in the prefrontal cortex and nucleus accumbens: a key to its antiparkinsonian effect in animals Neuropharmacology 42 2002 237 245
12. R.P. Downes, and J.L. Waddington Grooming and vacuous chewing induced by SK and F 83959, an agonist of dopamine 'D1-like' receptors that inhibits dopamine-sensitive adenylyl cyclase Eur. J. Pharmacol. 234 1993 135 136
13. E. Friedman, L.Q. Jin, G.P. Cai, T.R. Hollon, J. Drago, D.R. Sibley, and H.Y. Wang D1-like dopaminergic activation of phosphoinositide hydrolysis is independent of D1A dopamine receptors: evidence from D1A knockout mice Mol. Pharmacol. 51 2005 6 11
14. N. Gautam, G.B. Downes, K. Yan, and O. Kisselev The G-protein βγ complex Cell Signalling 10 1998 447 455
15. R. Gerber, C.A. Altar, and J.M. Liebman Rotational behavior induced by 8-hydroxy-DPAT, a putative 5HT-1A agonist, in 6-hydroxydopamine rats Psychopharmacology 94 1988 178 182
16. C.R. Gerfen D1 dopamine receptor supersensitivity in the dopamine-depleted striatum animal model of Parkinson's disease Neuroscientist 9 2003 455 462
17. H. Gille, M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M.H. Cobb, and P.E. Shaw ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation EMBO 14 1995 951 962
18. K.K. Gnanalingham, A.J. Hunter, P. Jenner, and C.D. Marsden Stimulation of adenylate cyclase activity by benzazepine D-1 dopamine agonists with varying efficacies in the 6-hydroxydopamine lesioned rat-relationship to circling behavior Biochem. Pharmacol. 49 1995 1185 1193
19. K.K. Gnanalingham, D.D. Erol, A.J. Hunter, L.A. Smith, P. Jenner, and C.D. Marsden Differential anti-parkinsonian effects of benzazepine D1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset Psychopharmacology 117 1995 275 286
20. K.K. Gnanalingham, A.J. Hunter, P. Jener, and C.D. Marsden The differential behavioural effects of benzazepine D1 dopamine agonists with varying efficacies, co-administered with quinpirole in primate and rodent models of Parkinson's disease Psychopharmacology 117 1995 287 297
21. T. Herdegen, and J.D. Leah Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox and CREB/ATF proteins Brain Res. Rev. 28 1998 370 490
22. P. Hughes, and M. Dragunow Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system Pharmacol. Rev. 47 1995 133 178
23. L.Q. Jin, S. Goswami, G. Cai, X. Zhen, and E. Friedman SKF 83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain J. Neurochem. 85 2003 378 386
24. P.A. Johansen, X.T. Hu, and F.J. White Relationship between D1 dopamine receptors, adenylate cyclase, and the electrophysiological responses of rat nucleus accumbens neurons J. Neural Transm. 86 1991 97 113
25. J.W. Kebabian, and D.B. Calne Multiple receptors for dopamine Nature 277 1979 93 96
26. C. Konradi, R.L. Cole, S. Heckers, and S.E. Hyman Amphetamine regulates gene expression in rat striatum via transcription factor CREB J. Neurosci. 14 1994 5623 5634
27. G.J. LaHoste, J. Yu, and J.F. Marshall Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity Proc. Natl. Acad. Sci. U. S. A. 90 1993 7451 7455
28. C. Le Moine, P. Svenningsson, B.B. Fredholm, and B. Bloch Dopamine-adenosine interactions in the striatum and the globus pallidus: inhibition of striatopallidal neurons through either D2 or A2A receptors enhances D1 receptor-mediated effects on c-fos expression J. Neurosci. 17 1997 8038 8048
29. R. Moratalla, M. Xu, S. Tonegawa, and A.M. Graybiel Cellular responses to psychomotor stimulant and neuroleptic drugs are abnormal in mice lacking the D1 dopamine receptor Proc. Natl. Acad. Sci. U. S. A. 93 1996 14928 14933
30. J.L. Neumeyer, N.S. Kula, J. Bergman, and R.J. Baskessarini Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines Eur. J. Pharmacol. 474 2004 137 140
31. K.M. O'Boyle, D.E. Gaitanopouos, M. Brenner, and J.L. Waddington Agonist and antagonist properties of benzazepine and thienopyridine derivatives at the D1 dopamine receptor Neuropharmacology 28 1989 401 405
32. G.J.O. O'Sullivan, B.L. Roth, A. Kinsella, and J.L. Waddington SK and F 83822 distinguishes adenylyl cyclase from phospholipase C-coupled dopamine D1-like receptors: behavioral topography Eur. J. Pharmacol. 486 2004 273 280
33. 35S]GTPγS binding and phosphoinositide hydrolysis in rat and monkey brain Neuropharmacology 40 2001 826 837
34. F.R. Pfeiffer, J.W. Wilson, G.Y. Kao, P.A. Chambers, K.G. Holden, R.A. Hahn, J.R. Wardell, A.J. Tobia, P.E. Setler, and H.M. Sarau Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines J. Med. Chem. 25 1982 352 358
35. H.A. Robertson, M.L. Paul, R. Moratalla, and A.M. Graybiel Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs Can. J. Neurol. Sci. 19 1991 380 383
36. R.K.W. Schwarting, and J.P. Hutson Unilateral 6-hydroxydopamine lesions of meso-striatal dopamine neurons and their physiological sequalae Prog. Neurobiol. 49 1996 215 266
37. M. Sheng, and M.E. Greenberg The regulation and function of c-fos and other immediate early genes in the nervous system Neuron 4 1990 477 485
38. C.S. Simpson, and B.J. Morriis Induction of c-fos and zif/268 gene expression in rat striatal neurons, following stimulation of D1-like dopamine receptors, involves protein kinase A and protein kinase C Neuroscience 68 1995 97 106
39. W.M. Struthers, and D. Wirtshafter Quinpirole attenuates the striatal Fos expression induced by escape behavior Brain Res. 7785 1998 347 350
40. P.H. Sugden, and A. Clerk Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors Cell Signalling 9 1997 337 351
41. P. Svenningsson, B.B. Fredhlom, B. Bloch, and C. Le Moine Costimulation of D1/D5 and D2 dopamine receptors leads to an increase in c-fos messenger RNA in cholinergic interneurons and a redistribution of c-fos messenger RNA in striatal projection neurons Neuroscience 98 2000 749 757
42. J.D. Sweatt The neuronal MAP kinase cascade: a biochemical signal integration system subserving synaptic plasticity and memory J. Neurochem. 76 2001 1 10
43. K. Tomiyama, F.N. McNamara, J.J. Clifford, A. Kinsella, N. Koshikawa, and J.L. Waddington Topographical assessment and pharmacological characterization of orofacial movements in mice: dopamine D1-like vs D2-like receptor regulation Eur. J. Pharmacol. 418 2001 47 54
44. A.S. Undie, and E. Friedman Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain J. Pharmacol. Exp. Ther. 253 1990 987 992
45. A.S. Undie, J. Weinstock, H.M. Sarau, and E. Friedman Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in the brain J. Neurochem. 62 1994 2045
46. E. Valjent, J.C. Corvol, C. Pages, M.J. Besson, R. Maldonado, and J. Caboche Involvement of the extracellular signal-related kinase cascade for cocaine-rewarding properties J. Neurosci. 20 2000 8701 8709
47. S.R. Vincent, S. Das, M. Grunert, L. WIlliams, and S.R. Vincent NMDA and D1 receptors regulate the phosphorylation of CREB and the induction of c-fos in striatal neurons in primary culture Synapse 25 1997 227 233
48. D. Wirtshafter, and K.E. Asin Interactive effects of stimulation of D1 and D2 dopamine receptors on Fos-like immunoreactivity in the normosensitive rat striatum Brain Res. Bull. 35 1994 85 91
49. D. Wirtshafter, and K.E. Asin Comparative effects of scopolamine and quinpirole on the striatal Fos expression induced by stimulation of D1 dopamine receptors in the rat Brain Res. 893 2001 202 214
50. D. Wirtshafter, K.E. Asin, and G. Schardt Compartmentally specific effects of quinpirole on the striatal Fos expression induced by a D1 dopamine agonist in intact rats Brain Res. 771 1997 271 277
51. Z.J. Zhang, X.L. Jiang, S.E. Zhang, C.J. Hough, H. Li, J.G. Chen, and X.C. Zhen The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm Neurosci. Lett. 382 2005 134 138
52. X. Zhen, S. Goswami, and E. Friedman The role of the phosphatidylinositol-linked D1 dopamine receptor in the pharmacology of SKF83959 Pharmacol. Biochem. Behav. 80 2005 597 601